
Global Intramedullary Nails Market Report and Forecast 2024-2032
Description
Global Intramedullary Nails Market Report and Forecast 2024-2032
Global Intramedullary Nails Market Report and Forecast 2024-2032
The global intramedullary nails market was valued at USD 736.47 million in 2023, driven by the increasing cases of fractures and increasing advantages over traditional fixation methods across the globe. The market is expected to grow at a CAGR of 6.6% during the forecast period of 2024-2032, with the values likely to reach USD 1,407.91 million by 2032.
Global Intramedullary Nails Market Analysis
Intramedullary nails are medical devices used primarily in the orthopaedic field for the fixation of bone fractures. These nails, also known as intramedullary rods, are inserted into the medullary cavity of a bone and serve as internal splints to maintain the alignment of the bone during healing. The use of intramedullary nails has become increasingly popular due to their ability to provide strong fixation with minimally invasive techniques, leading to faster recovery times and reduced hospital stays.
Market Drivers
- Increasing Incidence of Orthopaedic Injuries: The rising number of road accidents, sports injuries, and falls among the elderly population has significantly driven the demand for intramedullary nails. According to the World Health Organization, road traffic injuries are among the leading causes of disability and death globally, necessitating effective fracture management solutions.
- Ageing Population: The global increase in the elderly population, who are more susceptible to bone fractures due to osteoporosis and other age-related conditions, is another key driver. The United Nations projects that the global population aged 60 years and above will reach 2.1 billion by 2050, amplifying the demand for orthopaedic devices like intramedullary nails.
- Advancements in Technology: Technological advancements in the design and materials of intramedullary nails, such as the use of titanium and stainless steel for better biocompatibility and strength, have enhanced their efficacy and safety. Innovations like cannulated nails and locking mechanisms have further improved surgical outcomes.
- Increasing Healthcare Expenditure: Growing healthcare expenditure in both developed and developing countries has enabled greater access to advanced surgical procedures and medical devices, including intramedullary nails. Government initiatives and healthcare reforms aimed at improving orthopaedic care have also contributed to market growth.
- High Cost of Procedures: The high cost of intramedullary nail procedures can be a significant barrier, particularly in low and middle-income countries where healthcare budgets are constrained. This cost includes not only the device itself but also the associated surgical and post-operative care expenses.
- Stringent Regulatory Environment: The medical device industry is heavily regulated to ensure patient safety and device efficacy. Navigating the complex and varying regulatory requirements across different regions can be challenging for manufacturers, potentially delaying the introduction of new products to the market.
- Risk of Complications: Despite their advantages, the use of intramedullary nails can be associated with complications such as infection, nail breakage, and improper healing. These potential risks can deter both patients and surgeons from opting for this treatment method.
- Emerging Markets: The growing healthcare infrastructure in emerging markets presents significant opportunities for the intramedullary nails market. Countries in Asia-Pacific, Latin America, and Africa are witnessing increasing investments in healthcare, which is expected to boost the adoption of advanced orthopaedic treatments.
- Minimally Invasive Surgery Trends: The trend towards minimally invasive surgeries is likely to drive the demand for intramedullary nails, as these devices are integral to such procedures. Continued innovation in surgical techniques and nail designs to minimise surgical trauma and improve recovery times will further bolster market growth.
- Personalised Medicine: The integration of personalised medicine in orthopaedics, where treatments are tailored to the individual patient's anatomy and specific needs, offers promising opportunities. Customised intramedullary nails, designed using 3D printing technology, could become a reality, enhancing treatment outcomes and patient satisfaction.
- Collaborations and Partnerships: Strategic collaborations between medical device manufacturers, research institutions, and healthcare providers can foster innovation and expand market reach. Partnerships aimed at developing new technologies and improving access to orthopaedic care will be crucial in addressing unmet needs and driving market expansion.
Intramedullary nails have become a cornerstone in orthopaedic surgery for managing bone fractures. The market for these medical devices is witnessing dynamic trends driven by technological advancements, demographic shifts, and evolving healthcare practices.
Market Trends
- Technological Innovations: The intramedullary nails market is seeing significant technological advancements aimed at improving surgical outcomes and patient recovery. Innovations include the development of bioabsorbable nails, which gradually dissolve and eliminate the need for a second surgery to remove the implant. Additionally, smart intramedullary nails equipped with sensors to monitor bone healing are emerging, offering real-time data to surgeons.
- Shift Towards Minimally Invasive Techniques: There is a growing preference for minimally invasive surgical techniques in orthopaedics. Intramedullary nails are integral to these procedures as they allow for smaller incisions, reduced surgical trauma, and faster patient recovery. The market is benefiting from the increased adoption of these techniques, driven by patient demand for less invasive options and better post-operative outcomes.
- Customisation and Personalisation: The trend towards personalised medicine is making its way into the orthopaedic sector. Customised intramedullary nails, designed using advanced imaging and 3D printing technologies, are being developed to match the specific anatomical needs of individual patients. This approach aims to enhance the fit and performance of the nails, leading to better healing and patient satisfaction.
- Ageing Population: The global demographic shift towards an ageing population is significantly impacting the intramedullary nails market. Older individuals are more prone to fractures due to conditions like osteoporosis, leading to a higher demand for effective fracture management solutions. As the elderly population grows, so does the need for intramedullary nails, driving market expansion.
- Focus on Biocompatibility and Patient Safety: Manufacturers are increasingly focusing on the biocompatibility and safety of intramedullary nails. New materials such as titanium alloys and coated surfaces are being used to reduce the risk of infection and improve the integration of the nail with the bone. These enhancements are crucial for improving patient outcomes and reducing the incidence of post-operative complications.
- Geographical Expansion: Companies are expanding their geographical footprint to tap into emerging markets. Regions like Asia-Pacific, Latin America, and Africa are experiencing improvements in healthcare infrastructure and increased healthcare spending, creating opportunities for market growth. Strategic partnerships and collaborations with local distributors are helping manufacturers enter and establish a presence in these regions.
- Regulatory Developments: The regulatory landscape for medical devices, including intramedullary nails, is evolving. Stricter regulations and standards are being implemented to ensure the safety and efficacy of these devices. Companies are investing in regulatory compliance and quality assurance processes to meet these requirements, which can also serve as a competitive advantage.
- Sustainability and Eco-Friendly Practices: Sustainability is becoming an important consideration in the medical device industry. Manufacturers are exploring eco-friendly practices in the production of intramedullary nails, such as reducing waste, recycling materials, and using sustainable packaging. This trend aligns with the broader global emphasis on sustainability and environmental responsibility.
Global Intramedullary Nails Market Segmentation
Market Breakup by Type
- Long Gamma Nail (LGN)
- Trochanteric Femoral Nail (TFN)
- Intertroch/Subtroch Nail (ITST)
- Others
Market Breakup by Material
- Titanium Alloys
- Stainless Steel
Market Breakup by Application
- Femoral Fracture
- Tibial Fracture
- Others
Market Breakup by Category
- Upper Bone Extremities
- Lower Bone Extremities
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty/Orthopedic Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Intramedullary nails Market Competitive Landscape
The competitive landscape of the intramedullary nails market features key players such as Stryker Corporation, Orthofix Medical Inc., MICROMED Medizintechnik GmbH, B. Braun Melsungen AG, Smith & Nephew plc, Zimmer Biomet, Johnson & Johnson Services, Inc., Medtronic, Orthopaedic Implant Company, and GPC Medical Ltd. Common market activities include mergers and acquisitions to enhance market share and expand product portfolios. Research initiatives focus on developing innovative and biocompatible materials, while new product introductions aim to meet diverse surgical needs. Partnerships and collaborations with healthcare providers and research institutions are prevalent, driving technological advancements and improving patient outcomes. These activities collectively strengthen the market position of these key players, fostering competitive growth.
Key Questions Answered in the Report
- What is the current and future performance of the global intramedullary nails market?
- What are the main challenges facing the global intramedullary nails market?
- What are the key drivers of the global intramedullary nails market?
- What emerging trends are shaping the future of the global intramedullary nails market?
- How does personalised medicine impact the orthopaedic treatments market for intramedullary nails?
- How are new materials improving the biocompatibility and safety of intramedullary nails?
- Why is the Trochanteric Femoral Nail (TFN) expected to see significant market growth?
- How do sports injuries and accidents drive the market demand for tibial fracture treatments?
- What factors contribute to the rapid growth of the global intramedullary nails market in Europe and Asia Pacific?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global intramedullary nails market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global intramedullary nails market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global intramedullary nails industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Intramedullary Nails Market Overview
- 3.1 Global Intramedullary Nails Market Historical Value (2017-2023)
- 3.2 Global Intramedullary Nails Market Forecast Value (2024-2032)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Intramedullary Nails Market Landscape*
- 5.1 Global Intramedullary Nails: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Intramedullary Nails: Product Landscape
- 5.2.1 Analysis by Type
- 5.2.2 Analysis by Material
- 6 Global Intramedullary Nails Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Intramedullary Nails Market Segmentation (2017-2032)
- 7.1 Global Intramedullary Nails Market (2017-2032) by Type
- 7.1.1 Market Overview
- 7.1.2 Long Gamma Nail (LGN)
- 7.1.3 Trochanteric Femoral Nail (TFN)
- 7.1.4 Intertroch/Subtroch Nail (ITST)
- 7.1.5 Others
- 7.2 Global Intramedullary Nails Market (2017-2032) by Material
- 7.2.1 Market Overview
- 7.2.2 Titanium Alloys
- 7.2.3 Stainless Steel
- 7.3 Global Intramedullary Nails Market (2017-2032) by Application
- 7.3.1 Market Overview
- 7.3.2 Femoral Fracture
- 7.3.3 Tibial Fracture
- 7.3.4 Others
- 7.4 Global Intramedullary Nails Market (2017-2032) by Category
- 7.4.1 Market Overview
- 7.4.2 Upper Bone Extremities
- 7.4.3 Lower Bone Extremities
- 7.4.4 Others
- 7.5 Global Intramedullary Nails Market (2017-2032) by End User
- 7.5.1 Market Overview
- 7.5.2 Hospitals
- 7.5.3 Ambulatory Surgical Centers
- 7.5.4 Specialty/Orthopedic Clinics
- 7.5.5 Others
- 7.6 Global Intramedullary Nails Market (2017-2032) by Region
- 7.6.1 Market Overview
- 7.6.2 North America
- 7.6.3 Europe
- 7.6.4 Asia Pacific
- 7.6.5 Latin America
- 7.6.6 Middle East and Africa
- 8 North America Intramedullary Nails Market (2017-2032)
- 8.1 North America Intramedullary Nails Market (2017-2032) by Type
- 8.1.1 Market Overview
- 8.1.2 Long Gamma Nail (LGN)
- 8.1.3 Trochanteric Femoral Nail (TFN)
- 8.1.4 Intertroch/Subtroch Nail (ITST)
- 8.1.5 Others
- 8.2 North America Intramedullary Nails Market (2017-2032) by Material
- 8.2.1 Market Overview
- 8.2.2 Titanium Alloys
- 8.2.3 Stainless Steel
- 8.3 North America Intramedullary Nails Market (2017-2032) by Application
- 8.3.1 Market Overview
- 8.3.2 Femoral Fracture
- 8.3.3 Tibial Fracture
- 8.3.4 Others
- 8.4 North America Intramedullary Nails Market (2017-2032) by Category
- 8.4.1 Market Overview
- 8.4.2 Upper Bone Extremities
- 8.4.3 Lower Bone Extremities
- 8.4.4 Others
- 8.5 North America Intramedullary Nails Market (2017-2032) by End User
- 8.5.1 Market Overview
- 8.5.2 Hospitals
- 8.5.3 Ambulatory Surgical Centers
- 8.5.4 Specialty/Orthopedic Clinics
- 8.5.5 Others
- 8.6 North America Intramedullary Nails Market (2017-2032) by Country
- 8.6.1 United States of America
- 8.6.2 Canada
- 9 Europe Intramedullary Nails Market (2017-2032)
- 9.1 Europe Intramedullary Nails Market (2017-2032) by Type
- 9.1.1 Market Overview
- 9.1.2 Long Gamma Nail (LGN)
- 9.1.3 Trochanteric Femoral Nail (TFN)
- 9.1.4 Intertroch/Subtroch Nail (ITST)
- 9.1.5 Others
- 9.2 Europe Intramedullary Nails Market (2017-2032) by Material
- 9.2.1 Market Overview
- 9.2.2 Titanium Alloys
- 9.2.3 Stainless Steel
- 9.3 Europe Intramedullary Nails Market (2017-2032) by Application
- 9.3.1 Market Overview
- 9.3.2 Femoral Fracture
- 9.3.3 Tibial Fracture
- 9.3.4 Others
- 9.4 Europe Intramedullary Nails Market (2017-2032) by Category
- 9.4.1 Market Overview
- 9.4.2 Upper Bone Extremities
- 9.4.3 Lower Bone Extremities
- 9.4.4 Others
- 9.5 Europe Intramedullary Nails Market (2017-2032) by End User
- 9.5.1 Market Overview
- 9.5.2 Hospitals
- 9.5.3 Ambulatory Surgical Centers
- 9.5.4 Specialty/Orthopedic Clinics
- 9.5.5 Others
- 9.6 Europe Intramedullary Nails Market (2017-2032) by Country
- 9.6.1 United Kingdom
- 9.6.2 Germany
- 9.6.3 France
- 9.6.4 Italy
- 9.6.5 Others
- 10 Asia Pacific Intramedullary Nails Market (2017-2032)
- 10.1 Asia Pacific Intramedullary Nails Market (2017-2032) by Type
- 10.1.1 Market Overview
- 10.1.2 Long Gamma Nail (LGN)
- 10.1.3 Trochanteric Femoral Nail (TFN)
- 10.1.4 Intertroch/Subtroch Nail (ITST)
- 10.1.5 Others
- 10.2 Asia Pacific Intramedullary Nails Market (2017-2032) by Material
- 10.2.1 Market Overview
- 10.2.2 Titanium Alloys
- 10.2.3 Stainless Steel
- 10.3 Asia Pacific Intramedullary Nails Market (2017-2032) by Application
- 10.3.1 Market Overview
- 10.3.2 Femoral Fracture
- 10.3.3 Tibial Fracture
- 10.3.4 Others
- 10.4 Asia Pacific Intramedullary Nails Market (2017-2032) by Category
- 10.4.1 Market Overview
- 10.4.2 Upper Bone Extremities
- 10.4.3 Lower Bone Extremities
- 10.4.4 Others
- 10.5 Asia Pacific Intramedullary Nails Market (2017-2032) by End User
- 10.5.1 Market Overview
- 10.5.2 Hospitals
- 10.5.3 Ambulatory Surgical Centers
- 10.5.4 Specialty/Orthopedic Clinics
- 10.5.5 Others
- 10.6 Asia Pacific Intramedullary Nails Market (2017-2032) by Country
- 10.6.1 China
- 10.6.2 Japan
- 10.6.3 India
- 10.6.4 ASEAN
- 10.6.5 Australia
- 10.6.6 Others
- 11 Latin America Intramedullary Nails Market (2017-2032)
- 11.1 Latin America Intramedullary Nails Market (2017-2032) by Type
- 11.1.1 Market Overview
- 11.1.2 Long Gamma Nail (LGN)
- 11.1.3 Trochanteric Femoral Nail (TFN)
- 11.1.4 Intertroch/Subtroch Nail (ITST)
- 11.1.5 Others
- 11.2 Latin America Intramedullary Nails Market (2017-2032) by Material
- 11.2.1 Market Overview
- 11.2.2 Titanium Alloys
- 11.2.3 Stainless Steel
- 11.3 Latin America Intramedullary Nails Market (2017-2032) by Application
- 11.3.1 Market Overview
- 11.3.2 Femoral Fracture
- 11.3.3 Tibial Fracture
- 11.3.4 Others
- 11.4 Latin America Intramedullary Nails Market (2017-2032) by Category
- 11.4.1 Market Overview
- 11.4.2 Upper Bone Extremities
- 11.4.3 Lower Bone Extremities
- 11.4.4 Others
- 11.5 Latin America Intramedullary Nails Market (2017-2032) by End User
- 11.5.1 Market Overview
- 11.5.2 Hospitals
- 11.5.3 Ambulatory Surgical Centers
- 11.5.4 Specialty/Orthopedic Clinics
- 11.5.5 Others
- 11.6 Latin America Intramedullary Nails Market (2017-2032) by Country
- 11.6.1 Brazil
- 11.6.2 Argentina
- 11.6.3 Mexico
- 11.6.4 Others
- 12 Middle East and Africa Intramedullary Nails Market (2017-2032)
- 12.1 Middle East and Africa Intramedullary Nails Market (2017-2032) by Type
- 12.1.1 Market Overview
- 12.1.2 Long Gamma Nail (LGN)
- 12.1.3 Trochanteric Femoral Nail (TFN)
- 12.1.4 Intertroch/Subtroch Nail (ITST)
- 12.1.5 Others
- 12.2 Middle East and Africa Intramedullary Nails Market (2017-2032) by Material
- 12.2.1 Market Overview
- 12.2.2 Titanium Alloys
- 12.2.3 Stainless Steel
- 12.3 Middle East and Africa Intramedullary Nails Market (2017-2032) by Application
- 12.3.1 Market Overview
- 12.3.2 Femoral Fracture
- 12.3.3 Tibial Fracture
- 12.3.4 Others
- 12.4 Middle East and Africa Intramedullary Nails Market (2017-2032) by Category
- 12.4.1 Market Overview
- 12.4.2 Upper Bone Extremities
- 12.4.3 Lower Bone Extremities
- 12.4.4 Others
- 12.5 Middle East and Africa Intramedullary Nails Market (2017-2032) by End User
- 12.5.1 Market Overview
- 12.5.2 Hospitals
- 12.5.3 Ambulatory Surgical Centers
- 12.5.4 Specialty/Orthopedic Clinics
- 12.5.5 Others
- 12.6 Middle East and Africa Intramedullary Nails Market (2017-2032) by Country
- 12.6.1 Saudi Arabia
- 12.6.2 United Arab Emirates
- 12.6.3 Nigeria
- 12.6.4 South Africa
- 12.6.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 INDIA CDSCO
- 13.5 JAPAN PMDA
- 13.6 Others
- 14 Patent Analysis
- 14.1 Analysis by Type of Patent
- 14.2 Analysis by Publication Year
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Patent Age
- 14.5 Analysis by CPC Analysis
- 14.6 Analysis by Patent Valuation
- 14.7 Analysis by Key Players
- 15 Strategic Initiatives
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership and Collaborations
- 15.3 Analysis by Joint Ventures
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Market Share Analysis, By Region (Top 5 Companies)
- 16.1.1 Market Share Analysis: Global
- 16.1.2 Market Share Analysis: North America
- 16.1.3 Market Share Analysis: Europe
- 16.1.4 Market Share Analysis: Asia Pacific
- 16.1.5 Market Share Analysis: Others
- 16.2 Stryker Corporation
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 Orthofix Medical Inc.
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 MICROMED Medizintechnik GmbH
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 B. Braun Melsungen AG
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Smith & Nephew plc
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Zimmer Biomet
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 Johnson & Johnson Services, Inc.
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 Medtronic
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 Orthopedic Implant Company
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 16.11 GPC Medical Ltd.
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Mergers and Acquisitions
- 16.11.5 Certifications
- 17 Global Intramedullary Nails Market – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- *The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.